Bioimmulance Co., Ltd. (Japan)

Alternate names: Bioimmulance, Bioimmulance Co., Ltd., 株式会社バイオイミュランス

ROR: 00mqnm217

OpenAlex ID: I4405263992

Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy

2010 · Tsuguhide Takeshima, Kenji Chamoto, et al. · Cancer Research · 248

First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen

2012 · Norihiko Takahashi, Takayuki Ohkuri, et al. · Cancer Science · 62

Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine

2014 · Junya Ohtake, Takayuki Ohkuri, et al. · Immunology Letters · 29

Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells

2009 · T Ohkuri, D Wakita, et al. · British Journal of Cancer · 21

Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): Preparation and immunological analysis of vaccine efficacy

2014 · Kazutaka Masuko, Daiko Wakita, et al. · Immunology Letters · 13

Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cells

2014 · Yasuo Shiohama, Junya Ohtake, et al. · Immunology Letters · 12

Natural killer T cells from interleukin‐4‐deficient mice are defective in early interferon‐γ production in response to α‐galactosylceramide

2007 · Yuji Togashi, Kenji Chamoto, et al. · Cancer Science · 8

Works count: 7

Citation count: 1,897